233 related articles for article (PubMed ID: 32609820)
21. Massively parallel kinetic profiling of natural and engineered CRISPR nucleases.
Jones SK; Hawkins JA; Johnson NV; Jung C; Hu K; Rybarski JR; Chen JS; Doudna JA; Press WH; Finkelstein IJ
Nat Biotechnol; 2021 Jan; 39(1):84-93. PubMed ID: 32895548
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
[TBL] [Abstract][Full Text] [Related]
23. Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.
Schubert MS; Thommandru B; Woodley J; Turk R; Yan S; Kurgan G; McNeill MS; Rettig GR
Sci Rep; 2021 Sep; 11(1):19482. PubMed ID: 34593942
[TBL] [Abstract][Full Text] [Related]
24. The bridge helix of Cas12a imparts selectivity in cis-DNA cleavage and regulates trans-DNA cleavage.
Parameshwaran HP; Babu K; Tran C; Guan K; Allen A; Kathiresan V; Qin PZ; Rajan R
FEBS Lett; 2021 Apr; 595(7):892-912. PubMed ID: 33523494
[TBL] [Abstract][Full Text] [Related]
25. High-Performance Allosteric Conditional Guide RNAs for Mammalian Cell-Selective Regulation of CRISPR/Cas.
Hochrein LM; Li H; Pierce NA
ACS Synth Biol; 2021 May; 10(5):964-971. PubMed ID: 33930275
[TBL] [Abstract][Full Text] [Related]
26. Controlling Gene Expression in Mammalian Cells Using Multiplexed Conditional Guide RNAs for Cas12a*.
Oesinghaus L; Simmel FC
Angew Chem Int Ed Engl; 2021 Oct; 60(44):23894-23902. PubMed ID: 34533878
[TBL] [Abstract][Full Text] [Related]
27. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
[TBL] [Abstract][Full Text] [Related]
28. Functionalizing Cell-Free Systems with CRISPR-Associated Proteins: Application to RNA-Based Circuit Engineering.
Lehr FX; Kuzembayeva A; Bailey ME; Kleindienst W; Kabisch J; Koeppl H
ACS Synth Biol; 2021 Sep; 10(9):2138-2150. PubMed ID: 34383464
[TBL] [Abstract][Full Text] [Related]
29. Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles.
Ageely EA; Chilamkurthy R; Jana S; Abdullahu L; O'Reilly D; Jensik PJ; Damha MJ; Gagnon KT
Nat Commun; 2021 Nov; 12(1):6591. PubMed ID: 34782635
[TBL] [Abstract][Full Text] [Related]
30.
Ye Z; Moreb EA; Li S; Lebeau J; Menacho-Melgar R; Munson M; Lynch MD
ACS Synth Biol; 2021 Jan; 10(1):29-37. PubMed ID: 33331764
[TBL] [Abstract][Full Text] [Related]
31. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
32. Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.
Klompe SE; Vo PLH; Halpin-Healy TS; Sternberg SH
Nature; 2019 Jul; 571(7764):219-225. PubMed ID: 31189177
[TBL] [Abstract][Full Text] [Related]
33. Drug-tunable multidimensional synthetic gene control using inducible degron-tagged dCas9 effectors.
Kleinjan DA; Wardrope C; Nga Sou S; Rosser SJ
Nat Commun; 2017 Oct; 8(1):1191. PubMed ID: 29084946
[TBL] [Abstract][Full Text] [Related]
34. ErCas12a CRISPR-MAD7 for Model Generation in Human Cells, Mice, and Rats.
Liu Z; Schiel JA; Maksimova E; Strezoska Ž; Zhao G; Anderson EM; Wu Y; Warren J; Bartels A; van Brabant Smith A; Lowe CE; Forbes KP
CRISPR J; 2020 Apr; 3(2):97-108. PubMed ID: 32315227
[TBL] [Abstract][Full Text] [Related]
35. Optimization of AsCas12a for combinatorial genetic screens in human cells.
DeWeirdt PC; Sanson KR; Sangree AK; Hegde M; Hanna RE; Feeley MN; Griffith AL; Teng T; Borys SM; Strand C; Joung JK; Kleinstiver BP; Pan X; Huang A; Doench JG
Nat Biotechnol; 2021 Jan; 39(1):94-104. PubMed ID: 32661438
[TBL] [Abstract][Full Text] [Related]
36. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems.
Davidson AR; Lu WT; Stanley SY; Wang J; Mejdani M; Trost CN; Hicks BT; Lee J; Sontheimer EJ
Annu Rev Biochem; 2020 Jun; 89():309-332. PubMed ID: 32186918
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas12a
Li Y; Li T; Liu BF; Hu R; Zhu J; He T; Zhou X; Li C; Yang Y; Liu M
Chem Commun (Camb); 2020 Oct; 56(83):12526-12529. PubMed ID: 32966423
[TBL] [Abstract][Full Text] [Related]
38. Engineered RNA-Interacting CRISPR Guide RNAs for Genetic Sensing and Diagnostics.
Galizi R; Duncan JN; Rostain W; Quinn CM; Storch M; Kushwaha M; Jaramillo A
CRISPR J; 2020 Oct; 3(5):398-408. PubMed ID: 33095053
[TBL] [Abstract][Full Text] [Related]
39. In planta gene targeting can be enhanced by the use of CRISPR/Cas12a.
Wolter F; Puchta H
Plant J; 2019 Dec; 100(5):1083-1094. PubMed ID: 31381206
[TBL] [Abstract][Full Text] [Related]
40. The Expanding Class 2 CRISPR Toolbox: Diversity, Applicability, and Targeting Drawbacks.
Hajizadeh Dastjerdi A; Newman A; Burgio G
BioDrugs; 2019 Oct; 33(5):503-513. PubMed ID: 31385197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
